Selective anticancer drugs

被引：0
|
作者：
Joshua H. Atkins
Leland J. Gershell
机构：
[1] Managing Partners at AGW BioStrategy,
来源：
Nature Reviews Drug Discovery | 2002年 / 1卷 / 7期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：491 / 492
页数：1
相关论文
共 50 条
  • [21] MicroRNAs and anticancer drugs
    Xing, Zhiwei
    Li, Dongsheng
    Yang, Ling
    Xi, Yaguang
    Su, Xiulan
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 46 (03) : 233 - 239
  • [22] Viruses as anticancer drugs
    Russell, Stephen J.
    Peng, Kah-Whye
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (07) : 326 - 333
  • [23] THE DEVELOPMENT OF ANTICANCER DRUGS
    JARMAN, M
    CHEMISTRY IN BRITAIN, 1989, 25 (01) : 51 - 54
  • [24] NEW ANTICANCER DRUGS
    ROBERT, J
    BONNETERRE, J
    BULLETIN DU CANCER, 1995, 82 (04) : 247 - 247
  • [25] Bisphosphonates as anticancer drugs
    Mundy, GR
    Yoneda, T
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06): : 398 - 400
  • [26] Ruthenium anticancer drugs
    Alessio, E
    Iengo, E
    Serli, B
    Mestroni, G
    Sava, G
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 86 (01) : 21 - 21
  • [27] carrier of anticancer drugs
    Derakhshandeh, Katayoun
    Afshari, Majid
    Hosseinzadeh, Leila
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 : E165 - E165
  • [28] Intercalators as anticancer drugs
    Braña, MF
    Cacho, M
    Gradillas, A
    de Pascual-Teresa, B
    Ramos, A
    CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (17) : 1745 - 1780
  • [29] Combretastatin anticancer drugs
    Bibby, MC
    DRUGS OF THE FUTURE, 2002, 27 (05) : 475 - 480
  • [30] RESISTANCE TO ANTICANCER DRUGS
    ROBERT, J
    POUPON, MF
    MANFAIT, M
    BERNARD, J
    MARIE, JP
    LUCAS, P
    MUNCK, JN
    BULLETIN DU CANCER, 1990, 77 (11) : 1124 - 1124
12345